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and eight repeats of fibronectin type III (FnIII) domains
(Streuli et al., 1988). Ig domains are thought to function
as cell surface recognition structures and are found in
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Neil X. Krueger, Haruo Saito,
and Christin A. Frederick*
Dana-Farber Cancer Institute and several growth factor receptors such as PDGFR, FGFR,
and IL-6R as well as in cell adhesion molecules, includ-Department of Biological Chemistry and Molecular
Pharmacology ing the neural cell adhesion molecule (N-CAM). FnIII
domains are approximately 90 amino acids long andHarvard Medical School
Boston, Massachusetts 02115 contain a characteristic sequence motif identified ini-
tially in fibronectin. The combination of Ig and FnIII
domains is found in a number of known cell adhe-
sion molecules (CAMs) and matrix adhesion moleculesSummary
(MAMs). The CAM/MAM-like extracellular region of LAR
suggests that it may be an adhesion receptor. Recently,Most receptor-like protein tyrosine phosphatases
laminin was identified as a ligand for the extracellular(RPTPs) contain two conserved phosphatase domains
portion of LAR whose localization to focal adhesion sites(D1 and D2) in their intracellular region. The carboxy-
further supports such a cellular function (O'Grady et al.,terminal D2 domain has little or no catalytic activity.
1998).The crystal structure of the tandem D1 and D2 domains
In contrast to the divergent extracellular regions, theof the human RPTP LAR revealed that the tertiary
cytoplasmic regions of RPTPs are all very similar. Moststructures of the LAR D1 and D2 domains are very
of the RPTPs contain two tandem phosphatase do-similar to each other, with the exception of conforma-
mains, although a few RPTPs such as PTPb, DEP-1,tional differences at two amino acid positions in the
and U2 have been found to have only one PTP domainD2 domain. Site-directed mutational changes at these
(Krueger et al., 1990; Ostman et al., 1994; Seimiya et al.,positions (Leu-1644-to-Tyr and Glu-1779-to-Asp) con-
1995). An intriguing aspect of the tandem phosphataseferred a robust PTPase activity to the D2 domain. The
RPTPs is that the membrane-distal domain (D2) has, incatalytic sites of both domains are accessible, in con-
contrast to the membrane-proximal domain (D1), littletrast to the dimeric blocked orientation model pre-
or no catalytic activity (Streuli et al., 1990). Nonetheless,viously suggested. The relative orientation of the LAR
these D2 domains are thought to be vital because ofD1 and D2 domains, constrained by a short linker, is
their highly conserved primary sequences. Based onstabilized by extensive interdomain interactions, sug-
limited experimental evidence, it has been proposedgesting that this orientation might be favored in so-
that the D2 domains of most RPTPs may have a regula-lution.
tory function. Particularly in the case of CD45, the pres-
ence of the D2 domain has been shown to affect theIntroduction
activity of the D1 domain (Streuli et al., 1990). It has also
been suggested that the D2 domains may serve as anProtein tyrosine phosphatases (PTPs), in conjunction
additional substrate-binding site, and a protein has beenwith protein tyrosine kinases (PTKs), play essential regu-
identified whose binding is dependent upon the D2 do-latory roles in diverse cellular activities by modulating
main of LAR (Streuli et al., 1990). The D2 domain ofthe phosphorylation state of target proteins. The PTPs
RPTPa is unusual in that it does have slight catalyticidentified to date can be broadly divided into receptor-
activity of its own, although the substrate affinity andlike (RPTP) and cytosolic (nonreceptor) proteins. Each
specificity are much weaker than that of the correspond-member of the cytosolic PTP subfamily contains a con-
ing D1 domain (Wang and Pallen, 1991).served PTP domain of z240 amino acids in addition to
To date, several three-dimensional structures of ac-various accessory or regulatory domains such as an
tive PTP domains have been determined. These includeSH2 domain (Charbonneau and Tonks, 1992). Receptor-
the PTP domains of cytoplasmic protein tyrosine phos-like PTPs (RPTPs) are type 1 integral membrane proteins
phatases PTP1B, the Yersinia PTP Yop51, SHP-2, andcomposed of an extracellular receptor-like domain(s) as
the D1 domains of RPTPa and RPTPm (Barford et al.,well as a cytoplasmic region containing the catalytic
1994; Stuckey et al., 1994; Bilwes et al., 1996; HoffmannPTP domains. CD45 (also known as leukocyte common
et al., 1997; Hof et al., 1998). These structures of PTPantigen) and leukocyte antigen-related (LAR) protein are
domains, either alone or in complex with substratesthe prototypic members of the RPTP family, which now
or inhibitors, have provided a considerable amount ofincludes numerous proteins such as RPTPs a, b, g, d,
information about the catalytic mechanism. Biochemicale, z, k, and m (Saito, 1993).
studies, mainly of PTP1B, Yop51, and RPTPa, have con-The extracellular regions vary in size and structure,
firmed that certain invariant residues are directly in-among members of RPTPs as well as among isoforms
volved in binding substrate or stabilizing the reactionof a given molecule. The extracellular region of LAR is
intermediates (Zhang et al., 1994; Lohse et al., 1997;composed of three immunoglobulin (Ig)-like domains
Wu et al., 1997). However, many details regarding the
substrate specificity or the regulation of this activity* To whom correspondence should be addressed (e-mail: caf@
red.dfci.harvard.edu). remain unknown.
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et al., 1997). Since the D2 domain, an integral componentTable 1. Crystallographic Data and Refinement Statistics
of the regulation, was not included in these structures,
Crystallographic Data a clear evaluation of this dimer model or its general
Space group P21 application as a regulatory mechanism could not be
Cell parameters a 5 66.92 AÊ , b 5 62.73 AÊ , made.
c 5 161.59 AÊ , b 5 98.948 Our data, describing the three-dimensional structure
Z 4 of both phosphatase domains D1 and D2 of LAR, provide
X-ray source F1, CHESS
a direct structural basis for understanding the possibleResolution 50±2.0 AÊ
significance of this tandem domain arrangement inObservations (n) 267,242
RPTPs. In addition, the structural changes observed inUnique reflections (complete) 81,312 (90.7%)
Rsyma 0.064 D2 suggest a direct structural reason for its apparent
loss of catalytic activity as well as a possible means ofRefinement Statistics of Current Model
regulated activation of its intrinsic conserved phospha-
Resolution 20±2.0 AÊ tase architecture.
Protein atoms (n) 8,867
Water molecules (n) 472
Results and DiscussionRcryst (workb/freec) 0.222/0.274
Rmsd bond lengths 0.007 AÊ
Rmsd bond angles 1.338 Overview of the Structure
The 66 kDa fragment of LAR, residues 1308±1881, crys-a Rsym 5 ShSi|Iih 2 ,Ih.|/ShSi ,Ih., where ,Ih. is the mean of the
tallizes readily in space group P21 with two moleculesobservations Iih of reflection h.
b Rworking 5 S||F(obs)| 2 |F(calc)||/S|F(obs)|. in an asymmetric unit (Table 1). In both molecules, the
c Rfree 5 R factor for a selected subset (5%) of the reflections that fragment contains two well-defined PTP domains, D1
was not included in prior refinement calculations. and D2, connected by a four-residue linker (Figures 1
and 2). The structures of the two molecules are very
similar to each other with the exception of several sur-
A model for a regulatory mechanism has been sug- face loop regions and disordered segments within the
gested based on the crystal structure of the D1 domain first 35 residues of one molecule. In addition, there is a
of RPTPa (Bilwes et al., 1996). The D1 domain of RPTPa slight variability in the conformation of the linker region
crystallized as a dimer, and in the crystal each active connecting the two phosphatase domains such that the
site was blocked by an N-terminal helix-turn-helix seg- relative intramolecular orientation of the two domains is
ment of an opposing monomer, thus preventing sub- only slightly different in the two non±crystallographically
strate access to the active site. This coupled with related molecules (Figure 5A). If the atoms from the two
biochemical analyses of chimeric CD45/EGF receptor D1s are superimposed, the placement of the D2s differs
molecules has led to the suggestion that RPTP dimeriza- by a rotation of just 3.58, with an average difference in
tion might be a general mechanism of inactivation (Ma- position of z1.6 AÊ between the equivalent Ca atoms.
jeti et al., 1998). However, the residues of the N-terminal
wedge that are involved in the dimeric interactions in Domain Structure of D1 and D2
RPTPa are not well conserved in other RPTPs, and in In the current structure, both phosphatase domains
the structure of the D1 domain of RPTPm the same have the same overall tertiary fold as seen in the pre-
viously determined PTP structures, with an rmsd of onlyregions are not utilized for the dimer contacts (Hoffmann
Figure 1. Ribbon Diagrams of Two Views of the LAR D1D2 Molecule
D1 and D2 domains are shown in pink and cyan, respectively. On the left, the active site of D1 is facing the viewer and that of D2 is facing
upward. On the right, the same molecule is rotated along the horizontal axis approximately 908. (The relative positions of the two active sites
approach a 4-fold screw rotation.) Side chains of residues at the active sites are shown. The loops connecting b1 and b2 of D2 are shown
in magenta to indicate the location for the acidic 19-residue insertion in CD45. The boxed region is the interface between the D1 and D2
domains; a detailed view of this area is shown in Figure 5B. The figure was produced using the program SETOR (Evans, 1990).
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Figure 2. Sequence Alignment of PTP Do-
mains
The secondary structure elements are shown
on top using the nomenclature as defined for
the structure of PTP1B (Barford et al., 1994).
The residues are numbered as previously de-
scribed (Streuli et al., 1990). Residues from
the loops surrounding the active sites are
highlighted. Residues of RPTPa D1 that are
involved in dimeric interactions are indicated
with stars. Residues of the catalytic sites that
differ between the LAR D1 and D2 domains
are marked with diamond shapes. Residues
involved in the interdomain hydrogen bond-
ing are highlighted in cyan, and those from
the linker are highlighted in pink.
1.3 AÊ between all equivalent Ca atoms of D1 and D2. in the core of the protein and near the catalytic sites of
the PTP domains.The main features of each domain include a highly
twisted nine-stranded mixed b sheet flanked by four a Our structural data correlate with a number of previ-
ous biochemical observations. Mutational analyseshelices on one side and two on the other (Figure 1). The
two short elements of secondary structure, bx and by, showed that the whole D1 domain is required for cata-
lytic activity, and a deletion mutant ending at residuepresent in the PTP domains of RPTPs and SHP-2 phos-
phatase, could not be seen in our D1 structure due Ile-1550 in a5 of D1 is catalytically inactive (Streuli et
al., 1990). The activity was restored by extension throughto the shortened N terminus of the construct used for
crystallization. However, even without these b strands, the first 25 residues of the D2 domain. The structure
the N-terminal helix-turn-helix, a19 to a29, adopts the confirms these residues form the back side of the active
sharp turn seen in both the RPTPa D1 and RPTPm D1 site and are absolutely required for proper folding. Re-
structures. sults from point mutation experiments also agree with
The most obvious difference between LAR D1 and D2 the crystal structure (Tsai et al., 1991). Many mutations
is the presence of a longer loop, due to a four±amino with loss of function are located either at the active
acid insertion, between helices a19 and a29 in the D2 site or within the core of the protein, but temperature-
domain (Figure 3A). In the crystal structure, this loop sensitive mutations are located primarily within the
is involved in a crystallographic contact, adopting an amino-terminal portion of the D1 domain. These amino-
extended form. Whether this crystallographic interac- terminal residues are involved in the overall folding of
tion has any biological relevance is not known. Figure the protein, and the mutations weaken the structural
2 shows an alignment of amino acid sequences and stability of the entire molecule.
corresponding secondary structure elements for se-
lected PTP domains. The primary sequence comparison
Active Sites of the D1 and D2 Domainsshows that this four±amino acid insertion is shared by
The active site topologies within the two LAR domainsmany D2 domains, indicating the possible significance
are very similar to each other and to the other PTPs, allof this loop. Overall, the amino acid sequences are re-
with a cradle for phosphopeptide binding surroundedmarkably well conserved for both D1 and D2 domains,
by four loop regions (Figure 3B). Upon closer inspection,and this is reflected in the conserved secondary struc-
ture. Most of the highly conserved residues are found however, the structural differences resulting from the
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Figure 3. Comparisons between the LAR D1 and D2 Domains
(A) A superposition of main-chain atoms of the LAR D1 (pink) and D2 (cyan) domains. Disordered residues 1624±1627 of D2 are shown in
blue. The loop between the two N-terminal helices (a19 and a29) of D2 is marked with an arrow. The side chains of the active site Cys are
shown in yellow.
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substitution of two highly conserved residues appeared As shown in Figure 4, the wild-type GST-LAR-D1D2
is a very active enzyme. However, this phosphataseto account for the altered activity of D2. In PTP1B, Asp-
181 from the WPD loop has been shown to function as activity was completely abolished by the Cys-1522±Ser
mutation at the catalytic center of the LAR D1 domaina general acid in the catalytic reaction. In the structure
of the PTP1B±phosphopeptide complex, the WPD loop (D1C/SD21 mutant). In Figure 4B, using a 20-fold higher
concentration of enzymes than in Figure 4A, no releaseadopts a closed conformation with a large positional
shift of this aspartate toward the developing oxyanion of 32P by the GST-LAR-D1C/SD21 mutant protein was
observed above background even after 16 hr of incuba-(Jia et al., 1995). In LAR D1, no charged interaction or
steric hindrance is observed around its WPD loop that tion. We have previously demonstrated that purified LAR
D1D2 protein is stable under these conditions (Tsai etwould prevent such a shift of the corresponding Asp-
1490. In D2, however, the aspartate is replaced by Glu- al., 1991). Thus, it could be calculated that the activity
of the D1C/SD21 mutant protein is less than 0.001% of1779, which forms a hydrogen bond with the main-chain
amide group of Met-1718 from an adjacent loop. The that of the wild-type (D11D21) enzyme. The Cys-1522±
Ser mutation completely abolishes the LAR D1 activity,residues in this loop are not strictly conserved, and the
more rigid side chain of Met-1718 also provides some and there is no detectable activity due to the LAR D2
domain.steric hindrance that would further raise the energy re-
quirement for a ligand-induced shift of Glu-1779. It was then tested whether Leu-1644±Tyr (D2L/Y) and
Glu-1779±Asp (D2E/D) mutations have any effect on theAnother important substitution is in the so-called pTyr
recognition loop, where in the PTP1B±phosphopeptide D2 domain activity by incorporating these mutations
into the GST-LAR-D1C/SD21 mutant construct. As showncomplex a tyrosine residue was shown to interact with
the pTyr moiety itself. The conformation of PTP1B Tyr- in Figure 4B, the D1C/SD2L/Y double mutant protein has
phosphatase activity (about 0.5% of the wild-type en-46, as well as the corresponding LAR D1 Tyr-1355 in
this structure, is stabilized by a hydrogen bond formed zyme). The D1C/SD2E/D mutant protein also has a detect-
able activity, although it is only about 0.02% of thewith the serine immediately adjacent to the active site
cysteine. In LAR D2, where the tyrosine is replaced by wild-type enzyme. Thus, each of these mutations, Leu-
1644±Tyr and Glu-1779±Asp, converted the inactive D2Leu-1644, the serine shifts into the active site pocket to
form a water-bridged hydrogen bond with the main- domain to a detectably active enzyme. More impressive,
however, was the effect of the combination of the twochain amide of Gly-1818. This altered position of the
serine side chain blocks access to the catalytic Cys- mutations: the D1C/SD2L/Y E/D mutant protein had a level
of activity equivalent to that of the wild-type D1 domain1813 for potential phosphotyrosine substrates. The sur-
face models show that the active site Cys of D2 is not (Figure 4A). These observations corroborate the predic-
tion based on our LAR D1D2 structure that the two aminoeasily accessible from the outside, while the Cys of D1
is clearly visible and available for nucleophilic attack on acid positions, and only these two, are responsible for
the lack of catalytic activity in the D2 domain.an incoming phosphopeptide (Figure 3C). The loss of
stabilizing interactions from the tyrosine residue and the Although they had similar activity, the D2L/Y E/D enzyme
was clearly distinguishable from the wild-type D11 en-additional perturbation of the active site by Ser-1814
help explain the lower affinity of LAR D2 for phospho- zyme. Previously, we reported that the LAR D1 activity
peptide substrates. The rest of the residues in the signa- was enhanced when cationic polypeptides, such as poly-
ture motif (including Arg-1819 in D2) are positioned very lysine, were present in the reaction. Indeed, poly(Lys)
similarly in the two domains. The side chains of Gln- at 50 mg/ml enhanced the activity of the wild-type GST-
1566 and Gln-1857, whose corresponding residue in the LAR-D1D2 enzyme about 4-fold (Itoh et al., 1992). In con-
PTP1B±phosphopeptide structure was shown to form a trast, the activities of LAR-D1C/SD2L/Y, LAR-D1C/SD2E/D,
part of the phenyl ring±binding pocket, assume different and LAR-D1C/SD2L/Y E/D are inhibited 4-fold by poly(Lys)
conformations in the two LAR domains. However, no at the same concentration (data not shown). Although
structural restraints, which would prevent rotation of the mechanism of enzyme activation or inhibition by
these side chains upon ligand binding, were observed. cationic peptides is unknown, these results clearly dem-
onstrate the distinctiveness of the D1 and D2 derived
catalytic activities.Mutational Analysis
To investigate whether the amino acids at the two posi- The finding that only two amino acid changes make
the D2 domain a fully active enzyme poses an interestingtions, Leu-1644 and Glu-1779, are sufficient to explain
the lack of phosphatase activity in the LAR D2 domain, question as to the function of D2. This is even more
puzzling if we consider how well the D2 domain is con-we made a series of site-directed mutants in the D1 and
D2 domains of a GST-LAR-D1D2 fusion construct. The served among the related RPTPs, namely LAR, RPTPd,
RPTPs, and Drosophila DLAR. In these proteins, the D2construct contains LAR amino acid positions 1275±1881
(the natural C terminus of LAR). GST-LAR-D1D2 proteins domains are more highly conserved than the D1 do-
mains (Krueger et al., 1990). Our D2 structure and bio-were purified to near homogeneity by affinity chroma-
tography, and protein phosphatase activity was deter- chemical results indeed suggest that the LAR D2 domain
has a capacity to bind phosphotyrosyl peptides. How-mined using the 32P-labeled synthetic oligopeptide Ray-
tide (Streuli et al., 1990). ever, if the binding to such peptides is the only function
(B) A stereo view of the superimposed active sites of the D1 and D2 domains. Side chains of residues involved in catalysis are shown in pink
(D1) and cyan (D2). For emphasis, key residues used for comparison between D1 and D2 are colored individually.
(C) Surface representation of the active sites of D1 (left) and D2 (right). Residues involved in catalysis are shown in the color scheme following
that of the side chains in (B).
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Figure 4. Catalytic Activity of LAR PTP Mu-
tants
Phosphatase activities of purified GST-LAR-
D1D2 proteins were assayed using [32P-tyr]-
labeled Raytide at 378C for the indicated time.
Enzyme concentration in the assay reactions
was either 2.0 mg/ml (A) or 40 mg/ml (B). The
amount of radioactivity released as inorganic
phosphate is measured and expressed as the
percentage of total input radioactivity. (A)
Open circles represent LAR-D11D21; closed
circles, LAR-D1C/SD2L/Y E/D; and open squares,
LAR-D1C/SD21. (B) Open circles represent LAR-
D1C/SD2L/Y; closed circles, LAR-D1C/SD2E/D; and
open squares, LAR-D1C/SD21.
of the LAR D2 domain, it is unlikely that so many amino Relative Orientation and Interface
of the D1 and D2 Domainsacid positions that are essential for catalysis (although
In the LAR crystal structure, the D1 and D2 domains areprobably not for binding) would have been conserved.
oriented such that the active sites would be accessiblePresumably those amino acid positions are evolution-
from directions roughly 908 apart, with a linear separa-arily conserved because they are functionally relevant.
tion of greater than 40 AÊ . The two domains are con-Thus, it is possible that the LAR D2 domain is an intrinsi-
nected by a four-residue (Gly-His-Thr-Glu) linker (Figurecally active enzyme for specific substrates.
2). The exact positions and structures of this linker re-The D2 domain of RPTPa has been known to have
gion in both molecules in an asymmetric unit were verylimited catalytic activity (Wang and Pallen, 1991). It was
well defined in the initial electron density maps andrecently reported that two mutations in RPTPa, namely
were verified by omit map calculations (Figure 5A). TheVal-536±Tyr and Glu-671±Asp, which correspond to the
immediate proximity of rigid secondary structure ele-LAR-D2L/Y and D2E/D mutations, respectively, enhance
ments on either side of this linker is likely to limit itsthe D2 activity about 100-fold for p-nitrophenylphos-
degrees of positional freedom. Furthermore, this seg-phate (Lim et al., 1998; Buist et al., 1999). Thus, the
ment is involved in direct hydrogen bonds to the restchanges at these two amino acid positions seem a com-
of the molecule (Figure 5B). The main-chain carbonylmon mechanism to suppress the D2 catalytic activity.
group of Gly-1585 forms a water-bridged hydrogenThe mutated RPTPa D2 domain, however, did not show
bond with the terminal amide group of Arg-1505 (in a3 ofincreased activities for more complex substrates such
D1), and the main-chain amide group forms a hydrogenas phosphotyrosyl peptides, suggesting that in this case
bond with the carbonyl group of Ala-1581 from an adja-the microenvironment beyond the immediate phospho-
cent a helix. In addition, Og of Thr-1587 forms hydrogentyrosine binding site is also important for the catalysis.
bonds with Ne of Gln-1843 and Oe of Asp-1840 (in theThese results together with our structural data suggest
loop connecting by and a5 of D2). The residues at thethat for specific substrates, D2 may show high affinity
linker region are highly conserved with the Gly-1585 andthrough previously unseen specific interactions outside
Thr-1587 invariant in most of the RPTPs. The presence
of the binding site for the phosphotyrosine moiety. Since
of a glycine at the first position is critical, since only
the LAR D1C/SD2L/Y mutant protein showed significant
this residue can readily assume the respective φ and c
phosphatase activity, it is possible that once substrates angles of 658 and 21658 necessary to lock the orienta-
bind to the D2 domain with reasonable affinity, D2 can tion at the end of D1, and this in combination with the
be activated. This idea is further supported by the fact interactions of Thr-1587 described here leaves very lim-
that in PTP1B the change of the critical Asp into Glu in ited choices for linker conformations.
the WPD loop, in contrast to the Asp to Ala mutation, Additional intramolecular hydrogen bonds between
does not abolish the catalytic activity (Flint et al., 1997). the two domains are observed between residues from
However, it should be also noted that in the D2 do- b9, b10, and a3 of D1, and from a4 and the loop connect-
mains of several other RPTPs, such as PTPz and RPTPg, ing b2 and b3 of D2 (Figure 5B). In particular, hydrogen
the critical Cys in the signature motif is replaced by Ser. bonds are observed between the main-chain amide of
In the case of CD45, the D2 domain has the active site the Ala-1460 and the carbonyl of Tyr-1677 and among
Cys residue intact but alternatively has substitutions in the side chains of Arg-1506, Tyr-1462, and Glu-1836
several amino acids in the signature motif, including the bridged by a water molecule. As in the linker region,
critical Arg residue. Therefore, the D2 domains of these the residues involved in hydrogen bonding are highly
enzymes must be truly inactive, suggesting that in these conserved among the two-domain RPTPs. In addition,
cases the role of the second PTP domain would likely van der Waals interactions along the entire domain inter-
be a regulatory one, such as anchoring to or selecting face result in a tight and complementary fit of both do-
mains. All of these interactions are observed in bothsubstrates.
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Figure 5. The Linker and the Interface be-
tween the D1 and D2 Domains
(A) A simulated annealing 2|Fo|-|Fc| omit map
of the linker region of one molecule with the
respective final model included (shown in
cyan). The map is shown at the 0.85 s level.
The model shown in green represents the po-
sition of the linker from the second molecule
in an asymmetric unit once the D1 domains
of the two molecules were superimposed.
(B) Ribbon diagrams of residues involved in
hydrogen bonding. The region shown in this
figure is the detailed view, with the same ori-
entation, of the boxed area in Figure 1. Parts
of D1 and D2 are shown in pink on the left
and cyan on the right, respectively. Amino
acid residues involved in hydrogen bonding
between the two domains are shown with
carbon in gray, oxygen in red, and nitrogen
in blue. Water molecules are also shown in
red. Potential hydrogen bonds (2.5±3.3 AÊ ) are
drawn as dotted lines.
crystallographically independent molecules. These ex- Sequence alignment predicts that RPTP CD45 has
basically the same overall fold as LAR. An acidic 19-tensive intramolecular interactions between D1 and D2,
resulting in a buried surface area of approximately 650 residue insertion between b1 and b2 in the D2 domain,
which is present only in CD45, has been shown to alterAÊ 2, support the idea that the arrangement seen in the
crystal represents the limited flexibility of the relative substrate specificity of D1 toward synthetic peptides
(Streuli et al., 1990). Based on the intramolecular domainorientation of the two domains in solution.
Functional domains that are connected by long linkers orientation seen in the LAR crystal structure, the position
of this long insertion would be close enough to influenceas in the case of Grb2 (Maignan et al., 1995), can be
expected to operate independently to a large extent. substrate binding to D1 (see Figure 1), suggesting a
regulatory role for this loop.However, the limited flexibility in the relative orientation
and significantly large interdomain contact surface re- The crystal structure of RPTPa and transfection analy-
ses of chimeric CD45 molecules have led to the proposalported here suggests that, in the case of RPTP tandem
phosphatase domains such as LAR, the function of one that the catalytic activities of RPTPs are negatively regu-
lated by homodimerization between D1 domains throughdomain is highly likely to be dependent on the other.
Although no obvious structural evidence of direct inter- the N-terminal helix-turn-helix segment (Bilwes et al.,
1996; Majeti et al., 1998). Although the N-terminal helixdomain interactions at the active sites is observed, the
structural data do suggest how the interaction may af- wedge of LAR D1 maintains essentially the same confor-
mation as was observed for RPTPa D1, crystal packingfect the catalytic activity. In LAR, mutants missing the
N-terminal part (1614±1715) of D2 showed an altered analysis showed that this particular motif is not involved
in any intermolecular interaction. In fact, no extendedsubstrate specificity, while deletion of the C terminus
did not have this effect (Streuli et al., 1990). This contact surfaces were observed between the two crys-
tallographically independent LAR molecules. If in vivoN-terminal part of D2 is in close contact with D1 and
forms a wall at one side of the D1 active site. Although the relative orientation of the two domains is similar to
that seen in this crystal structure, the formation of LARthis region is not in direct contact with the specific cata-
lytic residues, the N-terminal segment of D2 is posi- dimers through the interaction of the N-terminal helix
wedge and the active site of D1 will be impossible be-tioned such that it could affect the binding of large sub-
strates. cause of steric hindrance by D2. Based on our structure,
Cell
456
it is possible that two molecules could interact through In the LAR crystal structure, the catalytic sites of both
a head-to-tail type of interaction, with D1 of one mole- domains are accessible. Since the LAR D1 and D2 do-
cule in contact with D2 of another molecule, but we did mains are constrained by a short linker and extensive
not see any indication of dimer formation for LAR, either interdomain interactions, it is likely that a similar relative
in the crystal structure or in solution. Size exclusion orientation exists in solution. The monomeric configura-
chromatography with protein concentrations up to 25 tion with open active sites is in direct contrast to the
mg/ml yielded only a monomer with the predicted mo- previous model of dimeric-blocked orientation based on
lecular mass of z66 kDa (data not shown). A monomeric the crystal structure of the RPTPa D1 domain alone
form is also consistent with what was observed in the (Bilwes et al., 1996). Our structural data demonstrate
crystal structure of RPTPm D1, where the catalytic site that the dimeric model should not be applied as a gen-
of this single domain was also open and unobstructed eral regulatory mechanism among RPTPs.
(Hoffmann et al., 1997). The intermolecular crystallo-
Experimental Proceduresgraphic contacts in that structure utilize a region of b
sheet that is involved in the LAR intramolecular contact
Crystallization and X-Ray Data Collectionsurface, the b9-b10 loop region (b8-b9 loop in RPTPm),
The recombinant fragment containing tandem D1 and D2 domainsand might be to some extent taking advantage of our
of the LAR protein (residues 1308±1881) with the addition of an
proposed interaction to help stabilize that crystal lattice. N-terminal methionine was expressed using a T7 expression system.
Recently, the D1 domain of RPTPs was shown to inter- Protein was purified by standard chromatographic methods using
act with the D2 domain of RPTPd, but not the RPTPs a DEAE column, followed by a Hydroxylapatite (HAP) column, and
finally by gel filtration using a Pharmacia Superdex 200 column. LARD2 with RPTPd D1 (Wallace et al., 1998). Although this
D1D2 crystals were grown by vapor diffusion in hanging drops at aexperiment did not provide any evidence as to whether
protein concentration of 20 mg/ml in 100 mM TrisHCl (pH 8.0), 8%±this interaction may be observed in the presence of both
16% (w/v) PEG 8000, 0.2 M Li2SO4. Crystals were flash-frozen withthe D1 and D2 domains of each protein, it does suggest 13% PEG 8000 and 25% glycerol. Diffraction data were collected at
that the D2 domain may be involved in a variety of inter- the F1 station of Cornell High Energy Synchrotron Source (CHESS).
molecular interactions. Images were processed with MOSFLM (Leslie et al., 1988), and data
were scaled and processed with CCP4 programs (CCP4, 1994).
From the unit cell dimensions, two molecules were expected in anConclusions
asymmetric unit (Table 1).Here, we have shown the three-dimensional structure of
tandem cytoplasmic PTP domains in the complete phos-
Structure Determination
phatase segment of the RPTP LAR. Because the major- The structure was determined by molecular replacement. Molecular
ity of RPTPs have a similar tandem domain arrangement, replacement was performed using an unaltered model of RPTPa D1
(PDB ID code 1yfo) as the search model with the program AMoRethe structural and biochemical data reported here
(Navaza, 1994). An initial search revealed four unambiguous posi-should provide a basis for understanding the activity
tions of phosphatase domains. After rigid-body refinement, mostand regulation of this important class of proteins.
side chains of the model, except for Gly and Ala residues, wereOverall structural homology was predicted for D1 and
substituted to Ser. Based on the 2|Fo|-|Fc| maps generated usingD2 based on the primary sequence comparison; how- the Ser-substituted model, the identities of the D1 and D2 domains
ever, the extreme conservation combined with the lack were assigned among the four possible positions. The high quality
of catalytic activity raises an important question regard- of the initial map made it possible to distinguish the side chains from
the different domains. Crystallographic refinement was performeding the function of D2. One possibility is that, because
using X-PLOR (BruÈ nger, 1990), applying noncrystallographic sym-the overall binding architecture is preserved, D2 func-
metry restraints (NCS). The NCS axis is parallel to a crystallographictions as an auxiliary binding site for phosphosubstrates.
symmetry axis, and the two molecules in an asymmetric unit areProtein tyrosine kinases, as well as soluble PTPs, fre- approximately related by a translation vector (1/2, 0, 1/2). Maps
quently contain domains, such as SH2 domains, special- were improved by multidomain averaging combined with solvent
ized in binding phosphotyrosine (Pawson, 1995). The flattening (CCP4). The model quality was checked by a series of
omit maps throughout the structure. The current model includes 566presence of a PTP domain with such a conserved overall
residues (starting Met and Ile-1038±Phe-1876 excluding disorderedarchitecture but with specific changes in key catalytic
residues 1624±1627) from one of the two molecules in an asymmetricresidues may explain the absence of such SH2-binding
unit, 542 residues from the second molecule, and 472 ordered watermodules in RPTPs. In our structure the active sites of
molecules. The N-terminal 34 residues of the second molecule are
the two domains of LAR are on opposite sides of the disordered in the model in such a way that the electron density was
protein, separated by 42 AÊ , and so are unlikely to accom- clearly visible at the same residue positions as those of the first
modate the same doubly phosphorylated substrate. This molecule. However, the individual positions could not be well re-
fined, and therefore these residues have been omitted from the finalindicates that the two domains are likely to bind to two
model. The slight difference in the crystal packing environment fordifferent proteins, thus bringing cellular components
the second molecule may be partly responsible for the disorder ofinto close proximity for further activation or interactions.
that N terminus. For the entire structure, 90% of the residues are
However, the very high degree of structural identity, in the most favored regions of a Ramachandran plot with only two
the conservation of the active site Cys, and our muta- residues in disallowed regions. These are identical residues from
tional data suggest a more complex role for D2. It is each molecule in an asymmetric unit where the main-chain carbonyl
is involved in a hydrogen bond. The final refinement statistics arepossible that D2 might in fact be an active PTPase do-
shown in Table 1.main in the correct cellular context. Either modification
of the protein itself or change in cellular environment
Mutational Analysismight activate this tightly regulated domain in vivo. De-
GST-LAR-D1D2 fusion protein was produced using pGEX2T-LAR-
termination of the conditions required for such activa- D1D2 (Furukawa et al., 1994), which contains LAR amino acid posi-
tion should lead to a better understanding of the true tions 1275±1881. Site-directed LAR mutants were generated by a
PCR method using mutagenic oligonucleotides, and the absencecellular role of this second conserved domain.
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of any secondary mutations was confirmed by sequencing. Wild- Lim, K.L., Kolatkar, P.R., Ng, K.P., Ng, C.H., and Pallen, C.J. (1998).
Interconversion of the kinetic identities of the tandem catalytic do-type and mutant GST-LAR-D1D2 proteins were expressed in E. coli
DH5 at 258C and purified to near homogeneity with glutathione- mains of receptor-like protein-tyrosine phosphatase PTP-a by two
point mutations is synergistic and substrate-dependent. J. Biol.Sepharose 4B (Pharmacia). PTPase activities of the purified proteins
were assayed using the synthetic peptide Raytide (Calbiochem) that Chem. 273, 28986±28993.
was tyrosine phosphorylated by the ABL kinase (Calbiochem) and Lohse, D.L., Denu, J.M., Santoro, N., and Dixon, J.E. (1997). Roles
g[p32]-ATP as a substrate, essentially as previously described (Streuli of aspartic acid-181 and serine-222 in intermediate formation and
et al., 1990). hydrolysis of the mammalian protein-tyrosine phosphatase PTP1.
Biochemistry 36, 4568±4575.
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